Symposia: Hemophilia A and B: Clinical and Epidemiological
	
	
	Program: Oral and Poster Abstracts
Type: Oral
Hematology Disease Topics & Pathways:
Research, Clinical trials, Bleeding and Clotting, Antibody Therapy, Adult, Hemophilia, Bispecific Antibody Therapy, Clinical Practice (Health Services and Quality), Clinical Research, Pediatric, Diseases, Patient-reported outcomes, Treatment Considerations, Biological therapies, Immunology, Monoclonal Antibody Therapy, Biological Processes, Study Population, Human
	Type: Oral
Hematology Disease Topics & Pathways:
Research, Clinical trials, Bleeding and Clotting, Antibody Therapy, Adult, Hemophilia, Bispecific Antibody Therapy, Clinical Practice (Health Services and Quality), Clinical Research, Pediatric, Diseases, Patient-reported outcomes, Treatment Considerations, Biological therapies, Immunology, Monoclonal Antibody Therapy, Biological Processes, Study Population, Human
Monday, December 9, 2024: 10:30 AM-12:00 PM
	Room 30 
		(San Diego Convention Center)
	
	
	
	
	   
	
	
			
		Moderators:
			
				
				
					
						
						
						
							Johnny Mahlangu, MD, 
						
					
					
				
					
						 and 
						
						
							Allison P. Wheeler, MD, ARRAY(0xe8aa018)
						
					
					
				
			
 
			
			Disclosures:
			
			
				
			
				
			
			Wheeler: Novo Nordisk: Consultancy, Honoraria, Research Funding; Octapharma: Research Funding; Bayer: Honoraria; BioMarin: Honoraria; Bioverativ: Honoraria; CSL Behring: Honoraria; Genentech: Honoraria; HEMA Biologics: Honoraria; Octapharma USA: Honoraria; Pfizer Inc: Honoraria; Sanofi-Aventis USA: Honoraria; Shire North America: Honoraria; Spark Therapeutics: Honoraria; Takeda Pharmaceuticals: Honoraria. 
			 
		This session will present the latest data on safety and efficacy of diverse novel hemostatic agents used for the prevention of bleeds in hemophilia A and B with and with inhibitors. The data on pediatric patients and long term effects of these therapies will be included.
	
	
	10:30 AM
	
	
10:45 AM
	
	
11:00 AM
	
	
11:15 AM
	
	
11:30 AM
	
	
11:45 AM
	
	
	
	
	See more of: Oral and Poster Abstracts
	
	
	
	
	*signifies non-member of ASH
					 
	
	 denotes an abstract that is clinically relevant.
 denotes an abstract that is clinically relevant. denotes that this is a recommended PHD Trainee Session.
 denotes that this is a recommended PHD Trainee Session. denotes that this is a ticketed session.
 denotes that this is a ticketed session.